Biotecnología

Biotecnología

FDA Roundup: September 20, 2022
22/09/2022 - The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
CytoReason Extends multi-Year Partnership with Pfizer
22/09/2022 - Will continue to provide its artificial intelligence technology for Pfizer’s drug development programs.
MedPharm to Support Mosanna Therapeutics in the Development of MOS-118
22/09/2022 - New drug aims to tackle Metabolic Obstructive Sleep Apnea.
Rokote Laboratories Licenses Cevec’s Proprietary CAP Ad Technology
22/09/2022 - Gains non-exclusive rights to use the CAP Ad platform for the manufacturing of adeno-based vaccines for prophylactic and therapeutic use in infectious diseases.
FDA Roundup: September 13, 2022
20/09/2022 - The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
UC San Diego Joins NIH ‘Bridge to Artificial Intelligence’ Program
20/09/2022 - UC San Diego scientists will lead several components of Bridge2AI, a new NIH-funded program to promote the use of AI in health and research.
BioIVT Acquires XenoTech
20/09/2022 - XenoTech specializes in ADME, DMPK and DDI testing of potential drug candidates.
Parexel Makes Key Leadership Appointments
20/09/2022 - Appointments focused on enhancing connections and collaboration to drive innovation across the next-gen delivery of clinical trials.
Decoupling from China on Clean Tech Comes with Far More Risks than Rewards
20/09/2022 - The current U.S. trajectory to decouple from China on clean energy technologies can harm national and global efforts to mitigate climate change, reveals a new University of California San Diego study...
QI Internship Provides Pathway to Workplace for Neurodiverse Youth
20/09/2022 - This summer, 16 young adults from around the U.S., including students at UC San Diego, gathered at the Qualcomm Institute (QI) to create educational and research-based video games in QI’s...
UC San Diego Physician, Alumni Partner to Provide Prosthetic Limbs for Ukrainian Amputees
20/09/2022 - A pilot program organized in Ukraine by LIMBER Prosthetics and Orthotics, a company co-founded by two alumni of UC San Diego Jacobs School of Engineering was was a first step in a much more ambitious...
Valneva and IDT Biologika Terminate Covid-19 Collaboration
20/09/2022 - In light of the reduced European Commission order, Valneva has suspended manufacturing of the vaccine.
Fujifilm Cellular Dynamics Names Ilyas Singeç as CSO
20/09/2022 - Previously served as the inaugural director of the Stem Cell Translation Laboratory.
FDA Roundup: September 16, 2022
20/09/2022 - The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Esta mascarilla detecta el coronavirus en el aire circundante y avisa al usuario por el móvil
20/09/2022 - Un equipo científico chino ha creado una mascarilla que...
PROFARSE elaborará fármacos a base de cannabis
15/09/2022 - El laboratorio público de medicamentos PROFARSE sigue creciendo desde Viedma para abarcar todo el país. Se trata de un gran paso que hasta el momento no se había dado y que...
$5M from NSF to Empower Transfer Students to Earn Engineering Degrees
13/09/2022 - With a $5 million grant from the National Science Foundation (NSF), the University of California San Diego is leading a new effort to support low-income transfer students pursuing a bachelor’s...
Honoring a UC San Diego Landmark and Its Lasting Impact on Physics
13/09/2022 - Is there magic in the walls of Mayer Hall? This is the question Oleg Shpyrko, chair of the Department of Physics at UC San Diego, asked the audience gathered for a daylong series of events to...
La vacuna de refuerzo contra la malaria de Oxford muestra una alta eficacia en ensayos con niños
13/09/2022 - Investigadores de la Universidad de Oxford han informado de los resultados de un ensayo en fase 2b, tras la administración de una dosis de refuerzo de su vacuna candidata contra la malaria,...
Medigen Expands Vaccine Development and Manufacturing Ops
13/09/2022 - Doubles the amount of space leased at Riverside Technology Park in Frederick, MD to 12,000 square feet.
Charles River, Cure AP-4 Enter Manufacturing Pact for Gene Therapy
13/09/2022 - Charles River will provide High Quality (HQ) plasmid DNA for Cure AP-4’s Phase I/II gene therapy trials against AP-4 HSP.